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Previous literature examining overall health outcomes and outcomes specifically related to adults 
with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have found disparities 
based on sociodemographic characteristics including race/ethnicity, gender, and socioeconomic 
status. There is currently little information known regarding demographic disparities in health 
outcomes for youth with ME/CFS symptomatology, though a recent prevalence study found 
Black and Latinx youth as well as females have higher rates of ME/CFS than White youth and 
males, respectively. The current study examined 137 youth who screened positive for ME/CFS 
symptomatology. Multiple linear regressions assessing demographic predictors on fatigue 
severity, number of symptoms endorsed, and overall physical functioning found females had 
worse outcomes associated with ME/CFS across all outcome variables and Latinx and Black 
youth had less fatigue severity compared to White youth. Results provide support for the need to 
target female youth in future diagnostic and treatment considerations for ME/CFS. Further 
examination is needed to understand the role of race/ethnicity and socioeconomic status in illness 
severity for ME/CFS symptomatology in youth. 
 
 









 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized as a 
debilitating chronic illness involving extended durations of fatigue as well as symptoms related 
to pain, sleep, neurocognitive abilities, immune and neuroendocrine functioning, and post-
exertional malaise (Fukuda et al., 1994; IOM, 2015; Jason et al., 2006; Reeves et al., 2003). 
Specifically in pediatric populations, ME/CFS has been found to cause impairments in various 
domains of life including physical functioning, school achievement, and involvement in 
activities outside of school such as sports (Josev et al., 2017; Kennedy et al., 2010; Torres-
Harding et al., 2006; Walford et al., 1993). Additionally, ME/CFS has been found to 
significantly debilitate children and adolescents, as only about 14% of those with the illness were 
able to attend school consistently in a study conducted by Krilov and colleagues (1998). 
Research has also shown many adolescents diagnosed with ME/CFS will continue to experience 
symptoms related to the illness and not return to pre-illness levels of functioning over time 
(Brown et al., 2012).  
 This evidence suggests ME/CFS in younger populations can cause significant issues in 
functioning across multiple life domains, and there is a strong need to better understand the 
disparities and risk factors associated with the illness in this population. Unfortunately, there are 
few studies addressing the symptomatology and prevalence of ME/CFS in diverse pediatric 
populations. Many epidemiological studies assessing prevalence and symptom severity rely on 
participants from tertiary care settings, which excludes those who may not have consistent access 
to care (Dobbins et al., 1997; Gunn et al., 1993; Lloyd et al., 1990). Therefore, these studies are 
biased in recruitment methodology and may not provide an accurate picture of those who are 
most at risk to be diagnosed with the illness. It is important to take into account the disparities 
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found in health care and diagnosis as well as to use a demographically diverse sample to better 
understand the presentation of ME/CFS in children and adolescents. 
Health Disparities and Access to Care 
 Due to the debilitating nature of ME/CFS for pediatric populations, it is vital to 
understand potential risk factors for the illness to better target prevention, diagnosis, and 
treatment strategies. Understanding the roles health disparities and access to care play in the 
severity of ME/CFS symptomatology in certain populations is an important first step needed to 
be taken within the field. Health disparities are differences in health outcomes in which those 
belonging to disadvantaged groups defined by race, ethnicity, social class, gender, and disability 
experience worse health than those of more privileged status (Braveman & Barclay, 2009). 
These health disparities extend past the individual level and may be the result of systemic 
inequalities surrounding certain individuals’ ability to access and utilize medical care on a 
regular basis. By understanding the impact of race/ethnicity, socioeconomic status, and gender 
on illness severity for pediatric populations, future research regarding diagnosis and treatment 
can be specifically tailored for those found to be most at risk. 
 Race/Ethnicity. Research has shown disparities in the prevalence of illnesses, access to 
care, and health outcomes for racial/ethnic minority children and adults (Nelson, 2002). A study 
by Newacheck and colleagues (2002) found children of racial/ethnic minority status with 
significant health care needs were more likely than White children to not have health insurance, 
not have access to a regular care source, and not be able to get medical care when needed. 
Additionally, Latinx and Black children were found to be less likely to be in good health when 
compared to White children, and these minority children and their parents were more likely to 
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report dissatisfaction with health care services due to not feeling heard by physicians and 
receiving referrals to specialists when needed (Flores et al., 2005).  
Further, Latinx individuals endorse higher rates of developing diabetes and certain 
cancers and experiencing job-related injuries, and also report higher mortality rates for HIV, all 
of which are influenced by lack of access to adequate health care and education (Vega, et al., 
2009). Latinx children and adolescents also have the highest rates of obesity (National Center for 
Health Statistics, 2016). These disparities in prevalence of illnesses are also mirrored in Black 
populations. For Black individuals, research has shown higher rates of cancer, diabetes, and heart 
disease when compared to White counterparts (Copeland, 2005; Peek et al., 2007; Singh & 
Jemal, 2017). Black individuals also have the highest rates of infant mortality and premature 
births (National Center for Health Statistics, 2016). In regards to access to care, issues regarding 
stigma associated with fears surrounding prejudice and discrimination have been examined as 
another barrier for access to care, especially for ethnic minority individuals and accessing mental 
health care (Gary, 2005). Taken together, this body of research suggests race/ethnicity may be a 
risk factor for the prevalence of illness and access to care and should be further examined in the 
context of ME/CFS. 
 Socioeconomic Status. In conjunction with differences in race/ethnicity, family income 
and parental education have also been found to associated with health disparities (Braveman, et 
al., 2001; Dubay & Lebrun, 2012). Adolescents from low-income families were found to have 
worse health outcomes and access to care than those of middle or high income families 
(Newacheck et al., 2003). Additionally, a study examining potential for chronic infection in 
children found children with lower household income and parental education had a higher 
likelihood of infection (Dowd et al., 2009). Asthma prevalence was found to be highest for Black 
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children of low-income status and low-income White children also had significant rates of 
asthma when compared to higher income counterparts (Akinbami et al., 2002). Mortality and 
incidence rates for cancer were also found to be higher for individuals with low income and 
lower educational status (Singh & Jemal, 2017). When considering parental education, a study 
by Chen and colleagues (2006) found there were worse outcomes in terms of overall health and 
physical activity for children whose parents had lower levels of education, especially for White 
and Black children.  
It is important to note Latinx and Black individuals have been found more likely to be 
lower income and have lower levels of educational attainment than White individuals, further 
increasing the risk for health disparities based on socioeconomic status in tandem with 
racial/ethnic minority status (Kocchar & Cilluffo, 2018; Ryan & Bauman, 2016). Latinx and 
Black individuals are also more likely to live in unsafe neighborhoods and die by homicide, 
suggesting environmental factors associated with lower income status may also contribute to 
disparities in health outcomes (Copeland, 2005; Vega et al., 2009).  
 Gender. Health disparities have also been found among male and female children, 
although research is mixed. For males, one study found Black males had the highest risk for 
strokes, and overall, males had higher rates of fatality for ischemic strokes when compared with 
females (Fullerton et al., 2003). Additionally, in a study examining childhood chronic illness, 
males were found to be at higher risk for behavioral problems than females (Gortmaker et al., 
1990). A recent review of gender disparities across a variety of domains of health found higher 
prevalence rates of obesity, autism spectrum disorder, and asthma for males when compared to 
females (Piccini et al., 2018). For females, this review found higher prevalence for rheumatic 
diseases and chronic pain conditions when compared to males (Piccini et al., 2018). 
6 
 
Additionally, in a study looking at children with end-stage renal disease (ESRD), female children 
were 14% less likely to be put on an organ transplant wait list than male children, leading to 
decreased chance for favorable outcomes related to the disease (Garg et al., 2000). A study by 
Thomas and colleagues (2011) also found female adolescents were more likely to screen positive 
for depression than males. There is significantly less research currently on health disparities 
related to gender for pediatric populations and further research is needed to provide clarity in this 
area regarding where disparities between males and females occur, especially within the area of 
chronic illness. 
Prevalence and Health Disparities in ME/CFS Literature 
 Pediatric Prevalence. It is important to understand the occurrence of ME/CFS in 
pediatric populations in order to best assess where disparities in symptomatology, prevalence, 
and access to care reside. While there have been numerous prevalence studies conducted to 
determine ME/CFS in youth populations, the methodology of many of these studies excludes 
whose who cannot or do not access regular medical care (Gunn et al., 1993; Dobbins et al., 1997; 
Lloyd et al., 1990) or did not include a medical evaluation, which can negatively impact 
diagnosis rates of the illness (Nijhof et al., 2011; Bakken et al., 2014; Collin et al., 2016). These 
studies recruited participants through physician referral which meant the youth had to have 
already accessed care to be included. Two subsequent studies utilized community-based 
recruitment methods. The first involved random digit dialing to households in San Francisco, 
California and found a prevalence rate of 116.4 per 100,000 for ME/CFS-like conditions for 
adolescents between the ages of 12 and 17 (Dobbins et al., 1997). The second community-based 
study involved random digit dialing in Wichita, Kansas and reported a prevalence rate of 338 per 
100,000 for ME/CFS-like illness in youth (Jones et al., 2004). A limitation across both studies 
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was there was not a medical evaluation included within the study so actual ME/CFS diagnosis 
prevalence was not calculated and only the prevalence of ME/CFS-like illness was found. Other 
prevalence studies including one based in Norway (Bakken et al., 2014) and one in the 
Netherlands (Nijhof et al., 2011) found pediatric ME/CFS rates of 43 per 100,000 and 111 per 
100,000 respectively and neither included a medical examination. A study based in Great Britain 
found prevalence of 1,900 per 100,000 for 16-year-olds but also did not include a medical 
examination, again yielding non-definitive results (Collin et al., 2016). In comparison, Jordan 
and colleagues (2000) incorporated a medical examination in their methodology and found a 
prevalence rate of 60 per 100,000. However, a significant amount of time elapsed between the 
initial phone screen and physician examination, which may have impacted the results.  
 A recent prevalence study with a community-based sample in the Chicagoland area, in 
which data for the current study were derived, was conducted involving both self-report 
measures and a medical and psychiatric interview (Jason et al., 2020). Results found the 
prevalence rate to be 750 per 100,000 for children ages 5-17 and 95% of these youth had not 
been previously diagnosed with ME/CFS. While this study has more fully encompassed those 
who may have the illness, the current review of the literature shows prevalence rates for pediatric 
ME/CFS have widely varied across studies with rates ranging from 2.7 to 1,900 per 100,000 
(Lloyd et al., 1990; Gunn et al., 1993; Dobbins et al., 1997; Chalder et al., 2003; Farmer et al., 
2004; Jones et al., 2004; Jordan et al., 2006; Rimes et al., 2007; Nijhof et al., 2011; Bakken et al., 
2014; Collin et al., 2016). This history of ambiguity in findings suggests less is known about the 
prevalence and subsequent presentation of the illness in pediatric populations which further 




 ME/CFS Disparities. A majority of the aforementioned studies above failed to report on 
prevalence rates or sample sizes for individual racial/ethnic groups or specific ages (i.e., child 
versus adolescent) and instead reported aggregated overall prevalence rates. A few studies did 
report specific rates based on gender (Lloyd et al., 1990; Jordan et al., 2006; Bakken et al., 2014, 
Jason et al., 2020), and found females to have higher rates of ME/CFS when compared to males. 
A majority of the studies only included adolescent samples, with the Jason and colleagues (2020) 
study being the only one to report rates for children as young as seven; results reported 
prevalence rates to be highest for older adolescents.  
The Jason and colleagues’ study (2020) and a study by Jordan and colleagues (2000) 
were the only pediatric studies to report prevalence rates based on race/ethnicity and found 
Latinx and Black youth to have higher prevalence rates when compared to White youth. 
Additionally, the Jason and colleagues (2020) study found female participants and adolescents to 
have higher prevalence rates as compared to males and younger children. Of note, both of these 
studies were community-based and not tertiary care referrals, reducing barriers to access to care. 
While the data is scarce in terms of reporting prevalence of ME/CFS for specific 
sociodemographic categories, there are indications from the two above mentioned studies that 
the highest occurrence of ME/CFS is seen for racial/ethnic minority individuals, females, and 
adolescents. Additionally, no studies of differences in symptomatology or fatigue severity were 
found in the literature based on sociodemographic groupings for youth with ME/CFS 
symptomatology. 
 Expanding the examination of sociodemographic differences in prevalence and 
symptomatology is important to better understand ME/CFS across diverse populations. A 
prevalence study conducted with an adult community-based sample found Latinx individuals 
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endorsed the highest prevalence rates across all racial/ethnic groups and females reported the 
highest rates in terms of gender (Jason et al., 1999). Additionally, this study found fatigue 
severity scores for both Latinx and Black participants were higher than White participants and 
there was a significant interaction between ethnicity and socioeconomic status on fatigue severity 
for this sample, suggesting a compounding effect of disparities (Song et al., 1999; Jason et. al., 
2000). A meta-analysis also found Black and Native American individuals had a higher 
likelihood for CFS and minorities with chronic fatigue reported greater symptom severity (Dinos 
et al., 2009). A study examining chronic fatigue and sociodemographic correlates found those 
with lower reported socioeconomic status as well as females and those with a psychological 
diagnosis had increased risk for CFS (Hickle et al., 1996). In regards to access to care, one study 
found access to an ME/CFS specialist was significantly lower for participants with lower 
household incomes and financial barriers were one of the most commonly cited reasons for a 
lack of access to care for individuals with ME/CFS (Sunnquist et al., 2017).  
 Some hypotheses have been offered regarding why racial/ethnic minority groups and 
those with lower socioeconomic status report more severe fatigue and have higher prevalence 
rates of fatigue. Possible explanations include the risk for poorer overall health status for 
minority groups due to lack of access to adequate medical care, stress due to outside social 
factors, and hazardous work experiences and living environments (Jason et al., 2000; Dinos et 
al., 2009). Additionally, one study posits that increased pressure to take care of one’s family due 
to cultural ideals and stress due to acculturation processes of Latinx populations may also 
account for increased risk for fatigue and higher fatigue severity (Song et al., 1999). The current 
study seeks to examine whether the findings reported in adult populations are similar for children 
in regard to ME/CFS symptomatology and fatigue severity in order to inform understanding of 
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where health disparities lie and how this may impact affected populations in regards to illness 
presentation and diagnosis. 
Outcomes Related to ME/CFS 
 Cardinal domains impacted by ME/CFS for pediatric populations include fatigue, sleep, 
pain, neurocognitive abilities, and immune and neuroendocrine functioning (Jason et al., 2006). 
Youth with ME/CFS also experience symptoms such as rashes and abdominal pain, a distinct 
difference compared to adult populations (Jason et al., 2006). Fatigue and other debilitating 
symptoms can lead to a decrease in physical functioning, with many children with the illness 
having to take extended leaves from school, being dependent on wheelchairs, or unable to leave 
the house (Dowsett & Colby, 1997; Rowe et al., 2017). Since ME/CFS can have substantial 
impacts on functioning due to symptom severity, it is important to examine how severe 
symptomatology is based on measures such as fatigue severity, quantity of severe symptoms 
reported, and overall physical functioning, which can be used to understand the impact of the 
illness in various life domains on youth.  
 Additionally, there is a lack of consensus regarding a universal case definition for 
ME/CFS diagnosis in the field. Prominent case definitions used currently for children and adults 
include the Fukuda (1994) Criteria, the IOM (2015) criteria, and the Pediatric Criteria (Jason et 
al., 2006). Due to this lack of consistency regarding diagnosis of the illness, it is important to 
examine how certain demographic variables such as gender, race/ethnicity, and socioeconomic 
status can influence the likelihood of receiving a diagnosis of ME/CFS across case definitions. 
Understanding the influence of sociodemographic variables can help to inform future diagnostic 
processes by illuminating whether certain groups receive diagnoses regardless of how severe 
their symptomatology is.  
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Theory: Life-Course Perspective 
 Previous research on broad health outcomes has revealed ethnic/racial minorities, 
females, and those with lower socioeconomic status are more at risk for developing a variety of 
illnesses, including ME/CFS, and having worse outcomes associated with these illnesses. One 
theory regarding health disparities, the life-course perspective, has provided an understanding for 
why these differences occur for historically disadvantaged groups (Arcaya et al., 2015; 
Braveman & Barclay, 2009).  
This framework promotes the need to examine multiple life stages and also account for 
social context when attempting to understand health disparities. Specifically, the life-course 
perspective acknowledges differences related to social group membership based on race, gender, 
and socioeconomic status can have an impact on health outcomes beginning in early childhood 
that may not be reversible even if the individual experiences subsequent positive life events 
throughout the rest of their lifespan (Braveman & Barclay, 2009). Additionally, even secondhand 
factors, such as parental education or occupation, can have an impact on health outcomes due to 
potential for limited social mobility, exposure to violence or hunger, and lack of access to care.  
The incorporation of sociodemographic characteristics that impact early childhood 
experience and potential for exposure to a variety of variables within this framework is useful for 
examining sociodemographic presentations of ME/CFS symptomatology in pediatric populations 
as well. Using this framework to examine causes of health disparities of disadvantaged 
populations as well as previous literature surrounding those with ME/CFS that points to 
disparities in ME/CFS health outcomes depending on sociodemographic grouping has shaped 




 There is no previous research related to symptomatology, fatigue severity and duration, 
overall physical functioning, and likelihood of an ME/CFS diagnosis for pediatric ME/CFS-like 
populations that is broken down using sociodemographic categories involving race/ethnicity, 
socioeconomic status, and gender. Understanding the differences in reports within these domains 
is essential when working to address health disparities and access to care through intervention 
and diagnostic strategies. In order to properly address disparities, we have to know where they 
are prevalent and at what level intervention is needed (i.e., is socioeconomic status more 
predictive of ME/CFS symptomatology than race/ethnicity, etc.).  
The present study seeks to address this gap in the literature by examining the relationship 
between sociodemographic variables (i.e., race/ethnicity, gender, socioeconomic status) and 
illness severity through measures of physical functioning, fatigue severity, and frequency of 
symptoms. A similar examination was conducted using an adult sample and results were used to 
hypothesize casual mechanisms of disparities and intervention focal points (Jason et al., 2000). 
Additionally, another study examining an adult sample found interactions in which racial/ethnic 
minority status and lower socioeconomic status further increased disparities in fatigue severity 
(Song et al., 1999). Thus, an investigation is imperative for pediatric ME/CFS populations, and 
the ability to do this is possible with the economically and racially diverse sample utilized in this 
study.  Understanding specific presentations of ME/CFS symptomatology based on 
sociodemographic variables and their interactions is the first step in developing tailored 
strategies to help manage and properly diagnose this illness in children and adolescents, which 
historically has been limited. 
Statement of Hypotheses 
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 Hypothesis I. Black and Latinx children with ME/CFS symptomatology will have worse 
outcomes associated with ME/CFS (i.e., fatigue severity, number of reported symptoms, 
decreased overall physical functioning, and likelihood of an ME/CFS diagnosis) than White 
children with ME/CFS symptomatology. 
Hypothesis II. Children with ME/CFS symptomatology with lower household income 
and lower parental educational attainment (some college or lower) will have worse outcomes 
associated with ME/CFS (i.e., fatigue severity, number of reported symptoms, decreased overall 
physical functioning, and likelihood of an ME/CFS diagnosis) than children with ME/CFS 
symptomatology having higher household income and higher parental educational attainment 
(completed a college degree or higher). 
Hypothesis III. Female children with ME/CFS symptomatology will have worse 
outcomes associated with ME/CFS (i.e., fatigue severity, number of reported symptoms, 
decreased overall physical functioning, and likelihood of an ME/CFS diagnosis) than male 
children with ME/CFS symptomatology. 
Hypothesis IV. Children with ME/CFS symptomatology who are members of multiple 
disadvantaged groups (i.e., gender, race, SES) will have worse outcomes related to ME/CFS (i.e., 
fatigue severity, number of reported symptoms, decreased overall physical functioning, and 
likelihood of an ME/CFS diagnosis) than those with ME/CFS symptomatology belonging to only 
one disadvantaged group. Specifically, outcomes will be worse for individuals with lower 





 Participants were taken from a community-based sample which was diverse across 
race/ethnicity, gender, and SES, as this was a community-based sample. Participants screened 
positive for ME/CFS-like symptomatology during an initial screener and 165 youth ages 6-17 
were originally included in the current study. After accounting for incomplete demographic data 
and outliers, a final sample of 137 youth was examined. 
 Recruitment. Participants for this study were recruited as part of a larger study of the 
prevalence of pediatric chronic fatigue syndrome (Jason et al., 2020). Phase one of the study 
involved calling 147,954 households in the Chicagoland area to administer a fatigue screener for 
youth ages 5-17 within each household. 5,622 households answered the phone and were willing 
to participate in the screener, resulting in 10,119 screened children and adolescents. To screen 
positive for ME/CFS symptomatology, parents who completed the screener had to endorse their 
child had fatigue at a moderate or greater severity and occurring at the least half of the time, at 
least one symptom related to school performance, and at least four other symptoms characteristic 
of ME/CFS as measured using the Pediatric ME/CFS Screening Questionnaire (Jason & 
Sunnquist, 2018). Additionally, any youth who had an explanatory reason for fatigue such as 
illness or intense physical activity were excluded from subsequent stages of the study. Screen 
positive participants from stage one were invited to participate in stage two of the study. 
Asymptomatic participants from screen one who were demographically similar based on age, 
gender, and race/ethnicity were invited to stage two as controls. For the present study, only those 
who screened positive for ME/CFS-like symptomatology (N=165) and participated in stage two 




















Figure 1. Methodology of Jason et al. (2020) study of pediatric ME/CFS 
Materials 
 Demographics. Parents were asked to complete questions regarding their race, gender, 
household income, marital status, educational status, household size, and religious affiliation as 
well as age, gender, race, and educational information regarding their child. Youth were asked to 
complete questions regarding age, gender, race, education, household size, and religious 
affiliation.  
 DePaul Pediatric Symptom Questionnaire (DPSQ). The DPSQ is a measure 
administered to both parent and youth separately that assesses ME/CFS symptoms and illness 
147, 954 Households 
Called 
Stage One: 10,119 
Screened (Ages 5-17) 
Stage Two: 237 
Children brought to 
Lurie Children’s 
Hospital  
165 Screen-positive  72 Screen-negative  
Stage Three: 75 




duration/history (Jason & Sunnquist, 2018). For the present study, the child responses were used 
to maintain consistency across measures. The DPSQ incorporates symptomatology from various 
case definitions, including the Fukuda et al. CFS criteria (1994), Canadian Clinical Criteria 
(Carruthers et al., 2003), and Institute of Medicine (IOM, 2015) criteria. The original 
questionnaire, the DePaul Symptom Questionnaire (DSQ), has been adapted for use with 
pediatric samples and has shown accurate case definition fulfillment with this population (Jason 
et al., 2006; Jason et al., 2009; Jason & Sunnquist, 2018).  
 Respondents were asked to rate the frequency of each of the 49 symptoms listed over the 
past three months on a Likert scale with 0 = “none of the time,” 1 = “a little of the time,” 2 = 
“about half the time,” 3 = “most of the time,” and 4 = “all of the time.” Respondents were also 
asked to rate the severity of each symptom listed over the past three months on a Likert scale 
with 0 = “symptom not present,” 1 = “mild,” 2 = “moderate,” 3 = “severe,” 4 = “very severe.” 
The frequency and severity score for each symptom was then multiplied by 25, creating 100-
point scales. The 100-point score for both frequency and severity was then averaged, creating a 
final composite score for each symptom. Lastly, respondents were asked to report how many 
total months they had experienced fatigue and this information was used to determine fatigue 
duration for fulfilling case definition criteria.  
 In terms of psychometric properties in adult samples, the DSQ has demonstrated good 
test-retest reliability for those with ME/CFS and control groups, α >.70 for a majority of items, 
(Jason et al., 2015; Jason & Sunnquist, 2018) and was found to have excellent internal reliability, 
α = 0.89-.96, while also accurately differentiating between those with ME/CFS and controls 
(Murdock et al., 2016; Jason & Sunnquist, 2018). Research is currently being conducted to 
examine psychometric properties for the DPSQ in pediatric populations. For the current sample, 
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internal consistency was α =.93. For this study, only symptoms reported to be at a threshold level 
of occurring at least half of the time and of moderate or greater severity were used for analyses 
regarding number of symptoms reported by the youth.  
Child Health Questionnaire (CHQ). The CHQ is a measure completed by the parent 
and child separately that examines overall physical and psychosocial well-being for the child 
(Landgraf et al., 1996). The child form (CHQ-CH87) is an 87-item measure and the parent form 
(CHQ-PF50) is a 50-item measure. Both versions include scales assessing physical functioning, 
role/social (behavioral, emotional, physical), general health perceptions, bodily pain, and self-
esteem. Two additional scales are found on the parent version, “Parent Impact- Emotional” and 
“Parent Impact-Time”. The CHQ has demonstrated good internal consistency, with Cronbach’s 
alphas averaging .72 across indices, and acceptable validity (Raat et al., 2002). The CHQ was 
also found to discriminate children with clinical conditions from controls, thus being found to 
have excellent discriminant validity (Landgraf et al., 1996; Raat et al., 2002). For this study, the 
domain assessing physical functioning was used for analyses as reported by the youth. Higher 
scores on this domain indicate better physical functioning. For the current sample, internal 
consistency was α=.85 on the physical functioning domain. 
Fatigue Severity Scale (FSS). This self-report scale (Krupp et al., 1989) was 
administered to children or adolescents and includes 9 statements about fatigue that are rated on 
7-point scales: 1 = “Strong disagree,” 4 = “Neither agree nor disagree,” and 7 = “Strongly 
agree.” Ratings are sensitive to different degrees of fatigue severity. Higher scores on the scale 
indicate more fatigue for the respondent. The FSS has been found to accurately discriminate 
between those with ME/CFS, multiple sclerosis, and depression (Pepper et al., 1993). Internal 
consistency was found to be high for this scale with chronic illnesses, α = .88 (Krupp et al., 
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1989) and test-retest reliability was adequate in a sample experiencing chronic pain, ICC = .95 
(Takasaki & Treleaven, 2013). The scale was found to differentiate individuals with ME/CFS 
from controls (Jason et al., 2011). This scale was used to measure overall fatigue severity as 
reported by the youth and internal consistency for this sample was α=.92. 
Case Definitions 
 Fukuda et al. (1994) criteria. Diagnosis based on this criteria requires relapsing or 
persistent fatigue for at least six concurrent months and at least four of eight somatic symptoms 
(cognitive impairment, sore throat, tender lymph nodes, muscle pain, joint pain, headaches, 
unrefreshing sleep, and post-exertional malaise) that did not begin before the onset of the fatigue. 
Substantial reduction in functioning is also required and fulfillment of this criteria is assessed 
through subscales of the CHQ parent and child forms. An example item measuring substantial 
reduction is “During the past 4 weeks, has it been difficult for you to get around your school, 
neighborhood, or playground due to health problems?” As defined by Reeves (2003), the child or 
adolescent could also not have any exclusionary medical or psychiatric conditions such as 
depression with melancholic features, obesity, or narcolepsy.  
 Pediatric criteria (Jason et al., 2006). The pediatric criteria was shaped by and adapted 
for pediatric populations based on the Canadian Clinical Criteria (Carruthers et al., 2003). This 
case definition requires unexplained or persistent fatigue that is not alleviated with rest and not 
the result of exertion. Substantial reduction in functioning is required and was measured using 
questions from the CHQ. Symptoms related to post-exertional malaise, unrefreshing sleep, pain, 
and neurocognitive difficulties are needed to meet criteria and will be assessed using the DPSQ. 
Additionally, at least one symptom from at least two of the following categories is required: 
autonomic, neuroendocrine, or immune. The pediatric criteria has been used with multiple 
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investigations including one that differentiated severe versus moderate symptomatology (Jason et 
al., 2009), one that compared diagnoses using the pediatric criteria and Fukuda (1994) criteria 
and found the pediatric criteria led to less misdiagnosis (Jason et al., 2010), and one that found 
21 adolescents with ME/CFS, who had longer time in bed and sleep time, and poorer sleep 
quality than controls (Josev et al., 2017). While this criteria typically requires three concurrent 
months of fatigue to meet case definition criteria, a threshold of six months of fatigue was used 
for this sample to maintain consistency across the three case definitions used. Participants could 
not have any exclusionary medical or psychiatric conditions in order to meet this criteria.  
 IOM (2015) criteria. The IOM criteria requires six or more months of concurrent fatigue 
that is not lifelong, alleviated by rest, or the result of ongoing exertion. Substantial reduction in 
functioning is required and was assessed using the CHQ. Symptoms associated with post-
exertional malaise (i.e., soreness after mild activity, dead/heavy feeling after exercise) and 
unrefreshing sleep (i.e., need to nap daily, problems failing or staying asleep) must also be 
present and was measured using symptoms on the DPSQ. Those who meet IOM criteria for 
ME/CFS must also have symptoms related to at least one of the two following: cognitive 
impairment (i.e., difficulty paying attention, difficulty finding the right word) or orthostatic 
intolerance (i.e., dizziness).   
Procedure 
The study procedures referenced were all approved by the Institutional Review Board of 
DePaul University. Participants attended a medical appointment at a children’s outpatient health 
center conducted by a pediatrician with expertise involving ME/CFS. The appointment involved 
a standard physical, a psychiatric interview, and collection of blood, saliva, and urine.  
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Prior to being seen by the medical doctor, participants and their parents were given 
consent/assent forms and completed the DePaul Pediatric Symptom Questionnaire (DPSQ; Jason 
& Sunnquist, 2018), the Fatigue Severity Scale (FSS; Krupp et al., 1989), and the Child Health 
Questionnaire (CHQ; Landgraf et al., 1996) via an online questionnaire service (REDCap; Harris 
et al., 2009). While completing the consent forms, participants and their parents were told the 
study was attempting to estimate the prevalence of chronic fatigue syndrome in children and 
children with and without fatigue were being examined. After the appointment, participants and 
their primary care physician received a summary letter from the medical doctor involved in the 
study detailing the results of the appointment and lab work in the mail.  
For stage three of the study, two physicians, not including the physician present at the 
medical appointments, reviewed each participant’s data and determined whether the participant 
meets case definition criteria for ME/CFS. The dichotomous outcome variable for this study, 
meets at least one case definition or does not meet any case definitions, was derived from this 
physician review process. 
Statistical Plan 
 All data was analyzed using SPSS version 23.0 (IBM Corp., 2015).  
Assumptions. Data were assessed to ensure it met the assumptions relating to regression 
analyses including completeness of data, linearity, normality, and homoscedasticity (Osborne & 
Waters, 2002). Little’s Missing Completely at Random test (Little, 1998) was run to determine if 
missing data for continuous outcome variables could be replaced utilizing imputation. Outliers 
were examined and removed utilizing the interquartile range method in which those exceed 2.2 
times the interquartile range were removed for outcome variables (Hoaglin & Iglewics, 1987). 
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Skewness and kurtosis values as well as data histograms were analyzed to determine data 
normality. 
 Demographic variables. For the race variable, only those participants who endorsed 
identifying as Latinx, Black, and White were used for analyses due to small sample sizes for 
other racial categories (i.e., Asian and multiracial; n=10). Dummy variables were created and 
utilized to compare Black participants with White participants, and Latinx participants with 
White participants. For the parent education variable, participants were collapsed into two 
groups: lower parental education attainment for those reporting less than a standard college 
degree and higher parental education attainment for those reporting a standard college degree or 
higher. Annual household income was operationalized on an ordinal scale, with six income 
categories ($0-49,999, $50,000-99,999, $100,000-150,000, $150,000-199,999, $200,000-000-
249,999, and $250,000 or more). For categorical variables, female was the reference category for 
the gender variable, lower parental education attainment was the reference category for the 
education variable, and White was the reference category for race variables. 
 Hypotheses I, II, and III. Multiple linear regression analyses (Aiken et al., 2003) were 
conducted with each of the continuous criterion variables separately, including fatigue severity 
as assessed by the FSS, number of threshold symptoms as assessed by the DPSQ, and overall 
physical functioning as assessed by the CHQ. This regression procedure allows for an 
examination of a dependent variable and multiple independent variables that may be continuous 
or categorical and attempts to model the relationship by constructing a linear model based on 
observed data. Using linear regression also allows an examination of the individual contribution 
of variance of each predictor while controlling for all other predictors, which is the main purpose 
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of this study. Predictor variables for each of these multiple linear regressions included gender, 
race/ethnicity, household income, and parental educational attainment.  
 Because the outcome variable for ME/CFS diagnosis was binary (met at least one case 
definition or did not meet any case definitions), binary logistic regression was used (Walker & 
Duncan, 1967). This method predicted the odds of a participant having a ME/CFS diagnosis 
based on the participants’ gender, race/ethnicity, household income, and parental educational 
attainment.  
Hypothesis IV. To assess whether belonging to multiple disadvantaged groups had a 
significant impact illness severity, significant linear regressions used to assess Hypotheses II, III, 
and IV were re-run with specifications that included interaction effects for variables with 
significant main effects in initial regression analyses. 
Results 
Participant Characteristics  
 165 screen-positive children and adolescents were originally included in the current 
study. Data were first assessed for missing values. Any participants who selected the answer 
choice “Prefer not to respond” for the annual income question (n=16) or who identified as 
multiracial or Asian (n=10) were excluded from all analyses. Outliers were removed if they fell 
beyond 2.2 times the interquartile range for continuous outcome variables (n=2). This left the 
final sample size at 137 participants. Participants were average age of 13.6 years (SD=2.6) and 
about half (54.7%) were female. In terms of race/ethnicity, approximately half (53.3%) identified 





Table 1. Demographic Characteristics of Screen Positive Participants 
  Screen Positive (n=137) 
  M (SD)  
Age 13.6 (2.6) 
  % (n) 
Gender   
Female 54.7 (75) 
Male 45.3 (62) 
    
Race/Ethnicity   
White 53.3 (73) 
Black 21.2 (29) 
Latinx 25.5 (35) 
    
Parent   
Reported Income   
$0-49,999 26.3 (36) 
$50,000 - $99,999 21.9 (30) 
$100,000 - 149,999 24.1 (33) 
$150,000 - 199,999 21.2 (29) 
$200, 000 - 249,999 2.9 (4) 
$250,000 or more 3.6 (5) 
    
Highest degree or level of education 
Less than high school 0.7 (1) 
High school or GED 12.4 (17) 
Partial college or specialized training 18.2 (25) 
Standard college degree 38.0 (52) 
Graduate or professional degree 30.7 (42) 
 
Preliminary Analyses 
Missing Data.  Little’s Missing Completely at Random (MCAR) test (1998) was not 
significant, χ2 = 12.36, p = 0.09, indicating data was missing completely at random and 
expectation maximization imputation methods were utilized using SPSS for the continuous 
outcome variables Fatigue Severity Score (missing n=1), Physical Functioning on Child Health 
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Questionnaire (missing n=2), and Number of Symptoms reported on DePaul Pediatric Symptom 
Questionnaire (missing n=7). Data with imputed values were used for all subsequent analyses. 
Regarding outcome variables, participants reported a mean FSS total score of 36.28, the mean 
number of symptoms endorsed on the DPSQ was 11.83, and the mean physical functioning score 
on the CHQ was 81.68 (Table 2).  
Table 2. Descriptive statistics of outcome variables (n=137)     
Variable M SD Range 
Fatigue Severity Scale Total Score 36.275 14.125 9-62 
Number of Symptoms at 2/2 on DPSQ 11.830 8.164 0-36 
Physical Functioning Score on CHQ 81.680 17.423 26-100 
        
Variable % (n)     
Case Definition Fulfillment        
     Met at least one ME/CFS Case Definition  48.2 (66)   
     Did not meet at least one ME/CFS Case Definition  51.8 (71)   
   
    
Assumptions. Regarding data normality, q-q plots were examined and skewness and 
kurtosis values were determined to be within an absolute value of two, indicating data were in an 
acceptable range for normality (George and Mallery, 2019). Statistical assumptions required for 
regression analyses were examined utilizing scatter plots, histograms, and variance inflation 
factor and tolerance scores and all factors were determined to be within normal limits.  
Primary Analyses 
 Model Summaries. Results indicated a significant linear regression model regarding the 
predictors income, education, race/ethnicity, and gender on the FSS total score (R2 = .12, 
F(5,131) = 3.40, p = .006; Table 3). The linear regression models regarding the demographic 
predictors on the number of symptoms reported on the DPSQ (R2= .07, F(5,131) = 2.02, p = 
.080; Table 4), the linear regression model regarding the demographic predictors on physical 
functioning reported on the CHQ (R2 = .06, F(5,131) = 1.80, p = .118; Table 5), and the binary 
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logistic model predicting case definition fulfillment based on demographic predictors 
(Nagelkerke R2  = .05, X2 (5) = 5.56, p = .352; Table 6) were not significant.  
Table 3. Linear regression predicting fatigue severity reported on FSS   
Predictors β Std. Error t value p value   
(Constant) 38.930 3.844 10.128 0.000   
Household Income -1.256 1.139 -1.103 0.272   
Parent Education 0.835 2.942 0.284 0.777   
Race: Black -6.923 3.372 -2.053 0.042 * 
Race: Latinx -7.869 2.934 -2.682 0.008 ** 
Child Gender 6.500 2.339 2.778 0.006 ** 
R-square = .115**; * p < .05; ** p < .01; *** p < .001     
 
Table 4. Linear regression predicting number of symptoms reported on 
DPSQ   
Predictors β Std. Error t value p value   
(Constant) 10.483 2.275 4.607 0.000   
Household Income -0.592 0.674 -0.878 0.382   
Parent Education 1.114 1.742 0.640 0.524   
Race: Black 0.500 1.996 0.250 0.803   
Race: Latinx -0.836 1.737 -0.481 0.631   
Child Gender 4.111 1.385 2.968 0.004 ** 
R-square = .071; * p < .05; ** p < .01; *** p < .001       
 
Table 5. Linear regression predicting child physical functioning reported on CHQ 
Predictors β Std. Error t value p value   
(Constant) 83.816 4.875 17.193 0.000   
Household Income -0.516 1.445 -0.357 0.722   
Parent Education 3.646 3.731 0.977 0.330   
Race: Black -0.566 4.277 -0.132 0.895   
Race: Latinx 3.406 3.721 0.915 0.362   
Child Gender -7.358 2.967 -2.480 0.014 * 






Table 6. Binary logistic regression predicting case definition fulfillment    
Predictors β Std. Error Wald p value Exp(B) 
(Constant) -0.272 0.690 0.155 0.694 0.762 
Household Income 0.123 0.171 0.518 0.472 1.131 
Parent Education -0.345 0.445 0.602 0.438 0.708 
Race: Black 0.294 0.512 0.329 0.566 1.342 
Race: Latinx -0.046 0.439 0.011 0.916 0.955 
Child Gender -0.488 0.354 1.897 0.168 0.614 
Nagelkerke R-square = .053; * p < .05; ** p < .01; *** p < .001     
 
 Hypothesis I. As reported in Table 3, race/ethnicity was found to be a significant 
predictor in the model assessing the FSS total score outcome for Black participants (β = -6.92, p 
= .042) and Latinx participants (β = -7.87, p = .008). The regression coefficients suggest less 
severity of fatigue as evidenced by lower scores on the FSS for both Black and Latinx groups. 
Race/ethnicity predictor variables were not significant for any other regression analyses. These 
findings do not support the hypothesis that racial/ethnic minority participants would experience 
worse outcomes related to ME/CFS when compared to White participants.  
 Hypothesis II. Socioeconomic status was not found to be a significant predictor for total 
FSS score, physical functioning on the CHQ, number of symptoms endorsed on the DPSQ, or 
probability of ME/CFS case definition fulfillment. This lack of findings does not support the 
hypothesis that lower household income or parent education attainment would contribute to 
worse outcomes associated with ME/CFS.  
 Hypothesis III. Gender was a significant predictor across all regression models with 
continuous outcome variables, including one predicting total score on FSS (β=6.50, p = .006; 
Table 3) in which the entire model was significant. Regression coefficients show female 
participants had higher total scores on the FSS when compared to males, indicating worse fatigue 
severity. Additionally, gender was a significant predictor for total number of symptoms at a 
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moderate threshold on the DPSQ (β = 4.11, p = .004; Table 4), with females reporting more 
symptoms and physical functioning on the CHQ (β = -7.36, p = .014; Table 5), with females 
reported decreased physical functioning. These results support the hypothesis that females would 
experience worse outcomes related to ME/CFS than males, even for nonsignificant models.  
 Hypothesis IV. Regression analyses were re-run including interaction effects for race by 
gender for the regression model predicting FSS due to significant main effects of gender and 
race. There were no significant interaction effects for any of the variables in the model (Table 7). 
This finding does not support the hypothesis that there would be a combined effect of multiple 
minority group identifications contributing to worse ME/CFS outcomes. Due to non-significance 
of main effects for any other predictors in all other regression analyses, interactions were not 
assessed. 
Table 7. Linear regression predicting fatigue severity with interactions     
Predictors   β Std. Error t value p value   
(Constant)   39.510 4.049 9.759 0.000   
Household Income -1.181 1.162 -1.016 0.311   
Parent Education 0.584 3.007 0.194 0.846   
Race: Black   -8.303 4.662 -1.781 0.077   
Race: Latinx   -8.900 4.170 -2.134 0.035 * 
Child Gender 5.407 3.290 1.644 0.103   
Gender by Race: Black 2.671 6.069 0.440 0.661   
Gender by Race: Latinx 1.943 5.716 0.340 0.734   
R-square = .117*; * p < .05; ** p < .01; *** p < .001       
 
Discussion 
 The current study is the first to examine the potential for health disparities in ME/CFS 
illness severity for a pediatric, community-based sample of screen positive participants. The 
results highlighted in this study provide a good starting point for future research examinations 
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regarding sociodemographic factors and their impact on functioning and symptomatology of 
ME/CFS.  
 Results of this study supported the hypothesis that female participants would exhibit 
worse functioning on ME/CFS illness severity outcome variables including number of symptoms 
reported, overall physical functioning, and fatigue severity when compared to males. Females 
reported more symptoms on the DPSQ, decreased physical functioning on the CHQ, and higher 
fatigue severity on the FSS. These results align with previous findings in adults with ME/CFS in 
that overall prevalence and illness severity are more severe for female participants (Hickle, et al., 
1996; Jason et al., 1999; Jason et al., 2000, Song et al., 2002; Song et al.,1999). This finding 
expands on previous knowledge relating to pediatric ME/CFS highlighting females have higher 
prevalence rates of the illness (Lloyd et al., 1990; Jordan, et al., 2006; Bakken et al., 2014, Jason 
et al., 2020) by showing females also have worse illness severity and functioning as compared to 
males. Taken together, these results point to the need for increased attention on females 
exhibiting symptoms characteristic of ME/CFS at both diagnostic and treatment levels as females 
are more likely to have the illness and more likely to report more severe symptomatology, 
increased fatigue, and diminished physical functioning when compared to males. Regarding 
clinical implications of this finding, clinicians should carefully consider gender as a risk factor 
for diagnosis of ME/CFS and should assess illness severity across various aspects in order to 
develop an appropriate diagnosis and treatment plan accounting for disparities evidenced in 
female youth with ME/CFS symptomatology. As noted within the life-course perspective 
(Braveman & Barclay, 2009), disparities present within early childhood can have negative 
impacts throughout the life span. Thus, early detection and attention to disparities such as those 
found with gender in this study are vital initial steps for addressing differences in illness 
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presentation in youth populations. A notable finding was that none of the demographic variables, 
including gender, successfully predicted ME/CFS case definition fulfillment in this sample. 
Perhaps this points to a greater need for clinician sensitivity and thorough analysis of patient 
symptomatology and functioning, as demographic risk factors alone do not predict likelihood of 
diagnosis. 
 The hypothesis that Black and Latinx youth would report worse outcomes related to 
ME/CFS than White youth was not supported in this study. Latinx and Black identity did 
significantly predict fatigue severity on the FSS; however, both groups reported less fatigue 
severity than White participants. This finding suggests that while Black and Latinx youth have 
higher prevalence rates of ME/CFS (Jordan et al., 2000; Jason et al., 2020), fatigue severity is 
not following this same pattern. This also does not align with findings in studies examining 
adults with ME/CFS, with Latinx and Black participants reporting higher fatigue severity than 
White participants (Song et al., 1999; Jason et. al., 2000). One potential reason for this disparity 
in findings may be lack of cultural validity for the FSS in racial/ethnic minority youth with 
ME/CFS symptomatology. There are currently no validation studies examining the use of the 
scale with racially/ethnically diverse youth. Therefore, differences in the understanding of 
ME/CFS or the concept of fatigue may be contributing to the finding that Latinx and Black youth 
report less fatigue severity than White youth. Disparities in access to health insurance and 
regular health care for racial/ethnic minority youth (Newacheck et al., 2002) may have also 
influenced youth reporting on illness severity, potentially due to unfamiliarity with health care 
systems or not feeling comfortable disclosing severity of symptoms. 
 A recent study by Grossman and colleagues (2020) found similar findings, with Black 
youth with a diagnosis of Crohn’s disease reporting less fatigue and anxiety than White youth 
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with this illness even though Black youth were found to have a more severe disease trajectory. 
The authors suggest potential reasons for this disparity include increased stigma regarding 
reporting on mental health, presence of resilience for Black youth, or differences in knowledge 
of the illness. This parallel in findings across two different chronic illnesses, Crohn’s disease and 
ME/CFS, suggest the need for more research in this area to better understand if factors such as 
stigma, resilience, or illness knowledge may play a role in reporting fatigue and other 
symptomatology in pediatric ME/CFS. Additionally, validating measures such as the FSS for 
diverse samples is imperative to understand whether differences in understanding of concepts 
like fatigue impact reporting. 
 The hypothesis that youth with lower socioeconomic status would report worse outcomes 
related to ME/CFS than youth with higher socioeconomic status was not supported. Similar to 
the potential for lack of access to healthcare or understanding of the illness in explaining findings 
for racial/ethnic minority groups, this may also be the case for youth with lower socioeconomic 
status, who may have underreported or conceptualized ME/CFS questionnaires differently when 
compared to youth with higher socioeconomic status. Findings from the Jason and colleagues’ 
(2020) pediatric prevalence study found only 4.8% of those diagnosed with ME/CFS had a prior 
diagnosis, suggesting a larger issue of underdiagnosis for the illness in pediatric populations. 
This highlights strong potential for lack of knowledge about illness symptomatology at time of 
reporting, which may be further impacted by other sociodemographic disparities described.  
Additionally, lack of significant findings across original regression models led to an 
inability to test most interaction effects between demographic variables. Future research with 
larger sample sizes should explore whether interactions among sociodemographic variables exist 
when significant main effects are found.  
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Limitations. The current study had several limitations which may have influenced the 
results. First, data for these analyses were derived from youth self-report measures. While 
internal consistency and other psychometric properties of the measures were acceptable, 
including other types of observable measures, such as biomarkers or physical tests of functioning 
during the medical appointment, would be a good direction for future studies. Additionally, all 
illness severity data was obtained by youth to maintain reporter consistency, as the FSS was only 
collected from youth participants. Incorporating parent reported data could also present a 
different perspective on youth’s illness severity, as previous work with a subset of this sample 
has found discrepancies in youth and parent reporting for ME/CFS symptomatology (Holtzman 
et al., 2018).  
This sample included a broad range of youth regarding illness severity, as those included 
only had to screen positive for ME/CFS symptomatology. While this allowed for the 
examination of predicting case definition fulfilment via binary logistic regression, this may have 
also been a limitation because it included those who did not ultimately receive a diagnosis for 
ME/CFS. Future research should attempt these analyses with a larger sample of those meeting 
case definition criteria for ME/CFS to determine if the impact of sociodemographic 
characteristics changes with a purely diagnosed sample. 
Finally, variables assessing socioeconomic status for this sample could be improved. A 
more robust measure of socioeconomic status by incorporating a more specific measure of 
income, household size, parental education, and insurance status may yield different results. 
Future studies should incorporate a more nuanced approach to socioeconomic status to determine 
its relationship to pediatric ME/CFS symptomatology.  
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Future Directions. Taking into account the life-course perspective and findings of this 
study, it is vital to continue to examine contextual factors which may be influencing reporting of 
illness severity. As Braveman & Barclay (2009) report, secondhand factors, such as parent 
education and income status as examined here, often play a role in health disparities. Thus, the 
need for a more nuanced approach to measuring socioeconomic status continues to be vital from 
a theory perspective. Additionally, other social factors such as stigma or resilience may also 
impact perception or reporting of illness for underrepresented groups. Continued examination of 
how social factors may impact reporting from a life-course perspective lens is warranted.  
It is important to note number of symptoms reported, overall physical functioning, and 
fatigue severity do not encompass all potential aspects of illness severity that can be measured. 
Future research should explore other measures of illness severity, such as emotional functioning, 
coping with illness, impact on school, and more to further understand how sociodemographic 
variables may influence those with ME/CFS symptomatology.  
The biggest finding of this study was that females reported worse outcomes related to 
ME/CFS across all measures of illness severity. It is imperative for clinicians and researchers to 
take this finding into account when designing diagnostic measures and piloting treatments to 
ensure those at risk for more severe symptomatology are targeted appropriately. Continued 
research regarding race/ethnicity and socioeconomic status can help illuminate other necessary 
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